Rybrevant

AMIVANTAMAB treats lung cancer. It works by helping your immune system slow or stop the spread of cancer cells. It is a monoclonal antibody.

With the Patient Assistance Program from Johnson & Johnson Patient Assistance Foundation, Inc., if you meet program requirements and are approved, you’ll receive your medication for up to one year.